0001144204-13-030742.txt : 20130521 0001144204-13-030742.hdr.sgml : 20130521 20130521133950 ACCESSION NUMBER: 0001144204-13-030742 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130517 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20130521 DATE AS OF CHANGE: 20130521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fuse Science, Inc. CENTRAL INDEX KEY: 0000842722 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870460247 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22991 FILM NUMBER: 13861021 BUSINESS ADDRESS: STREET 1: 6135 NW 167TH STREET STREET 2: #E21 CITY: MIAMI STATE: FL ZIP: 33015 BUSINESS PHONE: 305-503-3873 MAIL ADDRESS: STREET 1: 6135 NW 167TH STREET STREET 2: #E21 CITY: MIAMI STATE: FL ZIP: 33015 FORMER COMPANY: FORMER CONFORMED NAME: Double Eagle Holdings, Ltd. DATE OF NAME CHANGE: 20070123 FORMER COMPANY: FORMER CONFORMED NAME: ONSPAN NETWORKING INC DATE OF NAME CHANGE: 20010214 FORMER COMPANY: FORMER CONFORMED NAME: NETWORK SYSTEMS INTERNATIONAL INC DATE OF NAME CHANGE: 19960516 8-K 1 v345810_8k.htm FORM 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) May 17, 2013

 

 

 

FUSE SCIENCE, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Nevada

(State or Other Jurisdiction

of Incorporation)

     
000-22991   87-0460247

(Commission

File Number)

 

  

(IRS Employer

Identification No.)

 

   

6135 NW 167th Street, #E-21

Miami Lakes, Florida

  33015
(Address of Principal Executive Offices)   (Zip Code)

 

(305) 503-3873

(Registrant’s telephone number, Including Area Code)

 

 

 

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

Item 7.01 Regulation FD Disclosure

 

On May 17, 2013, Fuse Science, Inc. (the “Company”) issued a press release, announcing that a business update teleconference and webcast for shareholders and the investment community will be held on Wednesday, May 22, 2013, at 4:30 p.m. Eastern Time. Interested parties can listen to the live teleconference by dialing (877) 407-0782 from the U.S. or (201) 689-8567 for international callers. Individuals may access the live audio webcast by visiting http://www.investorcalendar.com/IC/CEPage.asp?ID=171023.

 

A replay of the teleconference will be available until June 5, 2013 which can be accessed by dialing (877) 660-6853 if calling within the U.S or (201) 612-7415, if calling internationally. Please enter conference ID #415071 to access the replay. A replay of the webcast will also be archived and available within the investor relations section of the Company’s web site at www.fusescience.com.

 

A copy of the press release is attached hereto as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits

 

 

Exhibit Number Description
   
99.1 Press Release dated May 17, 2013.

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   
  FUSE SCIENCE, INC.
   
 

/s/ Brian Tuffin

Brian Tuffin, Chief Executive Officer

Dated: May 21, 2013

 

 

 EX-99.1 2 v345810_ex99-1.htm PRESS RELEASE

 

EXHIBIT 99.1

 

Fuse Science, Inc. to Hold Business Update

Webcast and Teleconference on May 22nd

 

Miami Lakes, FL – May 17th, 2013 – Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals, announced today that it will hold a business update teleconference and webcast for shareholders and the investment community on Wednesday, May 22nd, 2013 at 4:30 PM ET.

 

Fuse Science, Inc. CEO, Brian Tuffin will host the call and will be joined by Rubin Hanan, President and COO and Jeanne Hebert, VP of Marketing and Clinical Research. Among the topics the Fuse executives will discuss include; distribution channel progress, third quarter sales growth and marketing updates, and an overview of current developments with the company’s science applications.

 

Interested parties can listen to the live teleconference by dialing (877) 407-0782 from the U.S. or (201) 689-8567 for international callers. Individuals may access the live audio webcast by visiting http://www.investorcalendar.com/IC/CEPage.asp?ID=171023.

 

A replay of the teleconference will be available until June 5, 2013 which can be accessed by dialing (877) 660-6853 if calling within the United States or (201) 612-7415, if calling internationally. Please enter conference ID # 415071 to access the replay. A replay of the webcast will also be archived and available within the investor relations section of the company’s web site at www.fusescience.com.

 

About Fuse Science, Inc.

 

Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida. Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).

 

For more information: To schedule an interview:
   
Fuse Science, Inc. Gus DeQuesada
Investor Relations Michelsen Advertising
Direct: (305) 503-3873, Ext. 2 C-305-733-1410 / 786-488-7138
Email: ir@fusescience.com prnews@michelsenadvertising.com